Home | Help Center

Endless possibilities in academia

ISSN: 2957-5443
Indexed in: Europub, Crossref, Dimensions, Google Scholar
Editor-in-Chief: Lize XIONG
Submit Review
Volume 3, Issue 3
A novel nasopharyngeal airway set-Nasal Pharyngeal Set-flexible

Chenglong Zhu1, Wenyun Xu1,2, Zui Zou1


1School of Anesthesiology, Naval Medical University, Shanghai 200433, China. 2Department of Anesthesiology, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.

 

Address correspondence to: Zui Zou, School of Anesthesiology, Naval Medical University, 168 Changhai Road, Yangpu District, Shanghai 200433, China. E-mail: zouzui@smmu.edu.cn.


DOI: https://doi.org/10.61189/156428jxplrz


Received October 26, 2024; Accepted January 7, 2025; Published September 30, 2025


Many patients, such as those who are obese, are prone to hypoxia during anaesthesia induction, painless gastroenteroscopy, and ICU sedation, which can lead to severe organ damage [1]. The traditional nasopharyngeal airway can effectively alleviate this problem, but it also introduces complications such as epistaxis [2]. NaPSflex (Nasal Pharyngeal Set-flexible) is a novel nasopharyngeal airway set developed by our team, designed to address difficult airways safely and simply. It has been registered as a medical device in China (Zhejiang Medical Device Registration Approval No. 20232081212).


NaPSflex consists of a reinforced catheter, a spring core, a restrictive nose plug, and an adapter (Figure 1). The reinforced catheter has small holes underneath for ventilation. With an outer diameter of only 4 mm, it prevents nasopharyngeal compression damage during catheter retention. The catheter is made of a flexible material to reduce the risk of nasal mucosa abrasion. The spring core is flexible, allowing easy access to the nasopharyngeal lumen. The restrictive nose plug regulates the catheter’s depth into the nasal cavity and helps secure it in place. Additionally, the catheter can be connected to either a nasal cannula or an anaesthesia machine’s breathing line via the adapter for oxygenation.


Several randomized controlled studies, approved by the Ethics Committee of the Naval Medical University and currently in the process of data collection, may provide robust evidence of its safety and efficacy. We believe that the new nasopharyngeal airway set can be widely adopted by anesthesiologists due to its potential in airway management.

Letter to the Editor |Published on: 30 September 2025

[Perioperative Precision Medicine] 2025; 3 (3): 71

DOI: https://doi.org/10.61189/156428jxplrz
PDF
CITE
Rescue of rocuronium-induced refractory anaphylax is with sugammadex in a laparoscopic hysterecto my: A case report

Rahul Kumar Chaudhary, Prajwal Bista*, Lalit Kumar Rajbanshi*, Kanak Khanal*


Department of Anesthesiology and Critical Care, Birat Medical College Teaching Hospital, Morang, 56613, Nepal.

 *The authors contribute equally.


Address correspondence to: Rahul Kumar Chaudhary, Department of Anesthesiology and Critical Care, Birat Medical College Teaching Hospital, Tankisinuwari, Dharan Road, Morang, 56613, Nepal. E-mail: rahulkr9991@gmail.com.


DOI: https://doi.org/10.61189/655401cvkjpp


Received June 24, 2025; Accepted August 29, 2025; Published September 30, 2025


Highlights 

 ● Anaphylaxis is a potentially life-threatening event during general anesthesia, with a rare incidence estimated at 1 in 10,000 to 1 in 20,000 cases. 

 ● Neuromuscular blocking agents, antibiotics, and latex are the primary triggers of perioperative anaphylaxis, with rocuronium being one of the most commonly implicated drugs. 

 ● Sugammadex is a valuable drug for reversing rocuronium-induced refractory anaphylaxis.

Case report |Published on: 30 September 2025

[Perioperative Precision Medicine] 2025; 3 (3): 72-75.

DOI: https://doi.org/10.61189/655401cvkjpp
PDF
CITE
Bibliometric analysis of traditional Chinese medicine in the prevention and treatment of Alzheimer's disease (2015-2024)

Xinyi Xie1,2,3*, Qin Zhang3,4*, Haiyi Qian1,2, Yan Zhang3,5, Dan Xia3,5, Yichen He2,5, Qixiang Xu1,3, Cuifeng  Zhang2,3,5 


1School of Pharmacy, Wannan Medical College, Wuhu 241002, Anhui Province, China. 2Anesthesiology Laboratory  and Training Center, Wannan Medical College, Wuhu 241002, Anhui Province, China. 3Wuhu Research and Development Center for Perioperative Monitoring and Prognostic Technology, Wannan Medical College, Wuhu 241002,  Anhui Province, China. 4School of Clinical Medicine, Wannan Medical College, Wuhu 241002, Anhui Province, China. 5School of Anesthesiology, Wannan Medical College, Wuhu 241002, Anhui Province, China. 

* The authors contribute equally.


Address correspondence to: Qixiang Xu, School of Pharmacy, Wannan Medical College, No.22 Wenchang West Road, Yijiang District, Wuhu 241002, Anhui Province, China. Tel: +86-18355305112.  E-mail: xuqixiang@wnmc.edu.cn; Cuifeng Zhang, School of Anesthesiology, Wannan Medical College, No.22 Wenchang West Road, Yijiang District, Wuhu 241002, Anhui Province, China. Tel: +86- 15551257181. E-mail: zhangcuifeng@wnmc.edu.cn.


DOI: https://doi.org/10.61189/949147feziwr


Received March 19, 2025; Accepted June 18, 2025; Published September 30, 2025


Highlights

● Summarize the latest research advances in Alzheimer's disease, including its pathogenesis, physiological biomarkers, and therapeutic strategies.

● Analyze the publication trends and current landscape of research on traditional Chinese medicine for Alzheimer's disease prevention and treatment using both quantitative and qualitative bibliometric methods.

● Summarize the therapeutic effects of traditional Chinese medicine and the discovery of novel treatment targets and pathways.

●Develop novel perioperative neurocognitive disorder therapies from Alzheimer's TCM research.

Review Article |Published on: 30 September 2025

[Perioperative Precision Medicine] 2025; 3 (3): 76-91.

DOI: https://doi.org/10.61189/949147feziwr
PDF
CITE
Unlocking the therapeutic potential of disulfiram in sepsis: Mechanisms and future directions

Qi Wu1,2,*, Wentao Ji1,*, Xiaoting Zhang1 , Qingshuang Zhang3 , Lulong Bo1

 

1Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai 200433, China. 2Department of Anesthesiology, 904th Hospital of The Joint Logistics Support Force of the PLA, Wuxi 214044, Jiangsu Province, China. 3Department of Pharmacy, Linyi People’s Hospital, Linyi 276000, Shandong Province, China.

* The authors contribute equally

 

Address correspondence to: Lulong Bo, Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, 168 Changhai Road, Yangpu District, Shanghai 200433, China. Tel: +86-021-31158021; E-mail: bartbo@smmu.edu.cn; Qingshuang Zhang, Department of Pharmacy, Linyi People’s Hospital, 27 Jiefang Road. Linyi 276000, Shandong, China. Tel: +86-13853997538; E-mail: zqs0417@163.


DOI: https://doi.org/10.61189/588589vgwoub

 

Received December 10, 2024; Accepted March 4, 2025; Published September 30, 2025


Highlights

● Disulfiram modulates sepsis through multiple mechanisms, potentially reducing excessive inflammation and improving patient outcomes.

● The immunomodulatory effects of disulfiram are complex, influencing inflammatory mediators and immune cell function, thereby restoring immune homeostasis.

● Translating preclinical findings into clinical practice is challenging. Rigorous clinical trials and a more comprehensive understanding of the pharmacokinetics and adverse effects of disulfiram are essential.

Review Article |Published on: 30 September 2025

[Perioperative Precision Medicine] 2025; 3 (3): 92-104.

DOI: https://doi.org/10.61189/588589vgwoub
PDF
CITE
Research progress on ferroptosis in the pathogene sis of sepsis

Yu Xiang, Jiameng Liu, Huan Li, Kecheng Zhai, Xingchen Yue, Shangping Fang


Anesthesia Laboratory and Training Center, School of Anesthesiology, Wannan Medical College, Wuhu 241002, Anhui Province, China.


Address correspondence to: Shangping Fang, Anesthesia Laboratory and Training Center, School of Anesthesiology, Wannan Medical College, No.22, Wenchang West Road, Lugang Street, Yijiang Dis trict, Wuhu 241002, Anhui Province, China. Tel: +86-19855362767; E-mail: 20180041@wnmc.edc. cn.


Acknowledgement: This work was supported by Anhui Province College Student Innovation and Entrepreneurship Project (S202310368027 and S202410368031).


DOI: https://doi.org/10.61189/843291jljiwm


Received December 12, 2024; Accepted February 14, 2025; Published September 30, 2025


Highlights 

 ●Lipid metabolism and iron metabolism pathways are key biological pathways involved in ferroptosis. 

● Ferroptosis exhibits complex crosstalk with other cell death forms in sepsis, with significant implications for dis   ease pathogenesis and therapy. 

● Ferroptosis plays a critical role in sepsis-related organ damage and prognosis. 

● This review suggests directions and perspectives for treating ferroptosis and sepsis in the perioperative period.

Review Article |Published on: 30 September 2025

[Perioperative Precision Medicine] 2025; 3 (3): 105-115.

DOI: https://doi.org/10.61189/843291jljiwm
PDF
CITE